Zymeworks
Vidhi Khanna is a Scientist in the in vivo Biology & PK (ADCs) division at Zymeworks Inc. since October 2023. Prior experience includes serving as a Senior Research Investigator and Research Investigator at Biocon - Bristol Myers Squibb Research Centre from September 2019 to September 2023. A summer internship at Seattle Genetics in 2017 involved developing an ELISA-based analytical method for quantifying Chinese Hamster Ovary (CHO) Host Cell Proteins (HCPs) and implementing a sample management system for over 30,000 samples. Early career experiences include internships in news reporting at IndiaBioscience, formulation R&D at IPCA, and analytical development at Cipla Ltd. Vidhi Khanna holds a PhD in Pharmaceutics and an MS in Pharmaceutical Sciences from the University of Minnesota, and a Bachelor of Pharmacy from the Institute of Chemical Technology India.
This person is not in any teams
This person is not in any offices
Zymeworks
2 followers
Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.